← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2016Last known activity
Oct 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 9 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT07167342CollaboratorPhase 4Oct 31, 2025
- NCT07152886CollaboratorPhase 4Oct 31, 2025
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT05965193CollaboratorPhase 3Aug 17, 2023
- NCT05965687CollaboratorPhase 3Aug 17, 2023
- NCT05794425CollaboratorPhase 1/Phase 2Aug 1, 2023
- NCT05901779CollaboratorN/AApr 1, 2023
- NCT05697055CollaboratorPhase 4Jan 21, 2023
- NCT02985372CollaboratorPhase 3Dec 1, 2016
Details
- Last known activity
- Oct 31, 2025